Related Experiment Video
Updated: Feb 1, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
Cystathionine β-synthase Induces Multidrug Resistance and Metastasis in Hepatocellular Carcinoma
Lupeng Wang1, Huanxiao Han1, Ya Liu1
1College of Pharmacy, Joint International Research Laboratory of Food & Medicine,Henan University, Kaifeng 475004, Henan Province, China.
Objective:
This study aims to analyze whether Cystathionine β-synthase (CBS) plays roles in hepatocellular carcinoma (HCC) drug resistance.
Methods:
MTS assay was used to detect the effect of chemotherapeutic drugs doxorubicin (DOX) and sunitinib on HCC cell viability and cell growth. Intracellular doxorubicin accumulation assay was performed to evaluate the sensitivity of DOX and sunitinib in HCC cells and the function of multidrug resistance-associated protein Pglycoprotein (P-gp). Quantification of H2S production was performed using the methylene blue method. Production of intracellular ROS was quantified using the DCFHDA assay. The scratch wound and transwell assays were used to determine the cell migration and invasion. Expression of proteins was tested by western blot analysis.
Results:
HepG2 cells with high CBS expression were less sensitive to DOX and sunitinib and knockdown of CBS significantly elevated the sensitivity to DOX and sunitinib in HepG2 cells. In contrast, CBS overexpression increased the resistance of DOX and sunitinib in BEL-7404 cells. Moreover, the overexpression of CBS caused the up-regulation of the expression level of P-gp and the decrease of DOX accumulation in BEL-7404 cells. In further mechanism research, we found that STAT3/Akt/Bcl-2 pathway activation, reactive oxygen species (ROS) inhibition as well as enhancement of the metastatic ability of hepatoma cells were responsible for the HCC drug resistance.
Conclusion:
CBS overexpression conferred HCC cell resistance.
Insights
Cystathionine β-synthase (CBS) overexpression increases resistance to chemotherapy drugs like doxorubicin and sunitinib in hepatocellular carcinoma (HCC) cells. Reducing CBS levels enhances drug sensitivity in HCC, highlighting CBS as a target for overcoming drug resistance.
Area of Science:
- Oncology
- Biochemistry
- Molecular Biology
Background:
- Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide.
- Drug resistance significantly limits the efficacy of chemotherapeutic treatments for HCC.
- Identifying novel molecular targets is crucial for improving HCC treatment outcomes.
Purpose of the Study:
- To investigate the role of Cystathionine β-synthase (CBS) in the development of drug resistance in hepatocellular carcinoma (HCC).
- To determine the impact of CBS expression levels on the sensitivity of HCC cells to common chemotherapeutic agents.
Main Methods:
- Cell viability assays (MTS) were used to assess drug sensitivity.
- Doxorubicin accumulation and P-glycoprotein (P-gp) expression were quantified.
- Hydrogen sulfide (H2S) and reactive oxygen species (ROS) levels were measured.
- Cell migration and invasion were evaluated using scratch wound and transwell assays.
- Protein expression was analyzed via Western blot.
Main Results:
- High CBS expression correlated with reduced sensitivity to doxorubicin (DOX) and sunitinib in HCC cells.
- Knockdown of CBS significantly increased HCC cell sensitivity to DOX and sunitinib.
- CBS overexpression led to increased P-gp expression and decreased DOX accumulation.
- CBS promoted HCC drug resistance via STAT3/Akt/Bcl-2 pathway activation, ROS inhibition, and enhanced metastasis.
Conclusions:
- CBS overexpression confers drug resistance in hepatocellular carcinoma.
- Targeting CBS may represent a viable strategy to overcome chemotherapy resistance in HCC.
Related Concept Videos
ATP Synthase: Structure
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
ATP Synthase: Mechanism
Resistivity
Resistance
Equivalent Resistance

